Media coverage about Owens & Minor (NYSE:OMI) has been trending somewhat positive on Wednesday, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Owens & Minor earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave media coverage about the company an impact score of 47.1069089421679 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Here are some of the news articles that may have effected Accern Sentiment’s rankings:
- Take-Two Interactive Software, SVB Financial and Nektar Pharmaceuticals Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (finance.yahoo.com)
- Owens & Minor, Inc. (OMI) Increases Dividend to $0.26 Per Share (americanbankingnews.com)
- March Undervalued Utilities Stock Opportunities (finance.yahoo.com)
- Barclays Initiates Coverage on Owens & Minor (OMI) (americanbankingnews.com)
A number of research firms have issued reports on OMI. Zacks Investment Research raised Owens & Minor from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Barclays began coverage on Owens & Minor in a research report on Thursday, March 8th. They issued an “underweight” rating and a $16.00 price target on the stock. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $22.00 price target on shares of Owens & Minor in a research report on Tuesday, December 19th. Credit Suisse Group reaffirmed an “underperform” rating and issued a $17.00 price target (down previously from $31.00) on shares of Owens & Minor in a research report on Monday, November 20th. Finally, ValuEngine lowered Owens & Minor from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Six equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. Owens & Minor currently has a consensus rating of “Hold” and an average target price of $24.28.
Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.34 by $0.01. Owens & Minor had a return on equity of 9.63% and a net margin of 0.78%. The business had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.34 billion. During the same quarter in the prior year, the business posted $0.52 EPS. The business’s revenue for the quarter was up .9% on a year-over-year basis. sell-side analysts forecast that Owens & Minor will post 2.06 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 15th will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, March 14th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 6.20%. This is an increase from Owens & Minor’s previous quarterly dividend of $0.26. Owens & Minor’s dividend payout ratio is presently 85.12%.
WARNING: “Owens & Minor (NYSE:OMI) Earns Media Sentiment Rating of 0.09” was originally reported by BBNS and is owned by of BBNS. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://baseballnewssource.com/2018/03/14/owens-minor-omi-receives-daily-news-impact-score-of-0-09/1971641.html.
Owens & Minor Company Profile
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.